KRELTAN Trademark

Trademark Overview

On Monday, May 3, 2010, a trademark application was filed for KRELTAN with the United States Patent and Trademark Office. The USPTO has given the KRELTAN trademark a serial number of 85028729. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 30, 2013. This trademark is owned by Glaxo Group Limited. The KRELTAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines
kreltan

General Information

Serial Number85028729
Word MarkKRELTAN
Filing DateMonday, May 3, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 30, 2013
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 28, 2010

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; and for vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 6, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGreenford, Middlesex UB60NN
GB

Trademark Events

Event DateEvent Description
Monday, December 30, 2013ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, December 30, 2013ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 23, 2013NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 22, 2013EXTENSION 5 GRANTED
Wednesday, April 17, 2013EXTENSION 5 FILED
Wednesday, April 17, 2013TEAS EXTENSION RECEIVED
Monday, March 25, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 25, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 15, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 15, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 14, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 13, 2012EXTENSION 4 GRANTED
Thursday, November 8, 2012EXTENSION 4 FILED
Thursday, November 8, 2012TEAS EXTENSION RECEIVED
Friday, May 18, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 17, 2012EXTENSION 3 GRANTED
Monday, May 14, 2012EXTENSION 3 FILED
Monday, May 14, 2012TEAS EXTENSION RECEIVED
Thursday, November 3, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 2, 2011EXTENSION 2 GRANTED
Monday, October 31, 2011EXTENSION 2 FILED
Monday, October 31, 2011TEAS EXTENSION RECEIVED
Thursday, April 21, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 20, 2011EXTENSION 1 GRANTED
Monday, April 18, 2011EXTENSION 1 FILED
Wednesday, April 20, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 18, 2011TEAS EXTENSION RECEIVED
Tuesday, November 23, 2010NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 28, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 28, 2010PUBLISHED FOR OPPOSITION
Tuesday, August 24, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, August 24, 2010ASSIGNED TO LIE
Friday, August 6, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 6, 2010ASSIGNED TO EXAMINER
Thursday, May 6, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, May 6, 2010NEW APPLICATION ENTERED IN TRAM

Related Keywords

kreltan pharmaceutical treatment substances disorders preparations diseases hormonal neurological gastrointestinal ophthalmic